论文部分内容阅读
本刊读者孙瑞文医师来信 ,问及 2型糖尿病合并冠心病患者对磺脲类口服降糖药的选择问题 ,这个问题不仅涉及到对不同磺脲类药物作用机制的了解 ,而且也有实际的临床意义。因此 ,编辑部特请本刊副主编陈家伟教授解答 ,现连同孙瑞文医师来信一并于本期发表 ,希望引起更多读者的关注。欢迎广大读者提出自己工作中遇到的问题 ,编辑部将根据问题的内容约请有关专家进行解答。
Our reporter Sun Ruiwen, a letter from the doctor, asked about type 2 diabetes mellitus patients with coronary heart disease sulfonylureas oral hypoglycemic choice, this question not only involves the understanding of the mechanism of action of different sulfonylureas, but also practical clinical significance . Therefore, the editorial department invited the magazine’s deputy editor Professor Chan Kar-wai to answer the question, and now Dr. Sun Rui-wen’s letter was also published in this issue in the hope of arousing more readers’ attention. The majority of readers are welcome to put forward their own problems encountered in the work, the editorial department will ask the relevant experts to answer according to the content of the question.